Table 2

Demographics and clinical characteristics of TRIAD participants
Without CHD History With CHD History
N 5914 2389
Age at baseline survey (SD) (years) 59.8 (12.3) 66.1 (10.4)
Female (%) 56.7 44.9
Race/Ethnicity (%)
  Non- Hispanic white 39.7 51.0
  Non- Hispanic black 17.3 15.9
  Hispanic 17.7 14.4
  Hawaiian/Pacific Islander 16.6 10.5
  Other 8.8 8.2
Duration (SD) (years) 10.6 (9.1) 13.6 (10.2)
History of CHD eventa (%) 0.0 100.0
HbA1C (SD) 8(1.9) 7.9(1.8)
Total Cholesterol (SD) (mg/dL) 200.8 (42.1) 191.9 (45.5)
HDL Cholesterol (SD) (mg/dL) 47.5 (12.9) 44.7 (12.8)
LDL Cholesterol (SD) (mg/dL) 116.1 (34.9) 108.8 (36.7)
Systolic Blood Pressure (SD) (mmHg) 136.4 (18.4) 136.7 (19.8)
Smoker (%) 18.5 17.5
Diabetes Treatmentb (%)
  Diet only 7.6 6.2
  Oral medication 66.0 57.5
  Insulin 14.0 20.1
  Insulin and oral medication 12.4 15.4
Other medicationb (%)
  Hypertension 68.7 88.5
  Statin 28.0 54.6
Co-morbidity Charlson’s scoreb (%)
  <1 5.2 1.9
  > = 1 to 2 44.0 17.4
  > = 2 to 3 28.9 24.1
  > = 3 21.9 54.6
Number of incident UKPDS CHD eventsc 120 199
Number of incident Framingham CHD eventsd 218 374
3.5-year UKPDS CHD event rate (95%CI) 3.0% 11.9%
(2.3%, 3.8%) (9.6%, 14.2%)
3.5-year Framingham CHD event rate (95%CI) 5.1% 20.9%
(4.2%, 6.0%) (17.9%, 23.9%)

aCHD history was identified in the medical record documentation, if at least one of the following conditions occurred in medical records 3 years prior to the baseline survey: angina, MI, other coronary heart disease or coronary artery disease, coronary angioplasty or bypass.

bData were obtained from 4602 patients without a CHD history and 2029 patients with a CHD history.

cUKPDS CHD event is defined as fatal or non-fatal MI.

dFramingham CHD event is defined as angina pectoris, MI, coronary insufficiency, sudden or non-sudden CHD death.

Lu et al.

Lu et al. BMC Endocrine Disorders 2012 12:12   doi:10.1186/1472-6823-12-12

Open Data